The effect of watercress on hemodialysis patients
- Conditions
- Patients undergoing chronic hemodialysis.Encounter for adequacy testing for hemodialysisZ49.31
- Registration Number
- IRCT20201228049866N1
- Lead Sponsor
- Yasouj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 75
18 years of age and older
Receive hemodialysis at least twice a week for about 3 months
Negative history of taking drugs affecting inflammatory markers such as corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs) in a recent month
Absence of active infectious diseases, malignant and other obvious inflammatory diseases
No history of taking tonics and anti-inflammatory drugs
Causes unpredictable drug side effects
Patients who refused to cooperate and continue the study and received the drug for less than 4 weeks
Development of active infectious diseases, cirrhosis and congestive heart failure and malignancy during the study and the need for kidney transplantation
Malnutrition and cachexia (body mass index less than 18 kg / m2)
Albumin less than 3
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood urea nitrogen. Timepoint: 0-28 days. Method of measurement: Autoanalyzer.;Triglyceride. Timepoint: 0-28 days. Method of measurement: Autoanalyzer.;Cholestrol. Timepoint: 0-28 days. Method of measurement: Autoanalyzer.
- Secondary Outcome Measures
Name Time Method Protein carbonyl. Timepoint: 0-28 days. Method of measurement: colorimetric.;Interleukin 6. Timepoint: 0-28 days. Method of measurement: Sandwich Enzyme-Linked ImmunoSorbent Assay.;Tumor Necrosis Factor Alpha(TNF-a). Timepoint: 0-28 days. Method of measurement: Sandwich Enzyme-Linked ImmunoSorbent Assay.;Vitamin E. Timepoint: 0-28 days. Method of measurement: High-performance liquid.;Vitamin C. Timepoint: 0-28 days. Method of measurement: High-performance liquid.